Navigation Links
Larry Flynt Argues for the Legalization of Marijuana
Date:5/3/2012

LOS ANGELES, May 3, 2012 /PRNewswire/ -- With recent polls showing that 50% of Americans favor the legalization of marijuana, Mr. Flynt is asking why steps are not being taken to make that a reality. Mr. Flynt places blame on those that have the most to lose from legal weed: the pharmaceutical, alcohol and prison industries.

Pharmaceutical companies don't want people turning to pot for pain relief because it means they'll be spending less on prescription pills. The alcohol industry doesn't want the competition, either. With mounting scientific evidence that pot is safer than alcohol, legal marijuana would clearly put a major dent in the booze business' profits. Private, for-profit prisons only make money if they're full, and that means locking up weed growers and pot smokers.

"This is what's wrong with America," said Mr. Flynt. "Our elected politicians ignore the people's wishes and do the bidding of the corporations that line their pockets with cash."

Follow Larry Flynt on Twitter @ImLarryFlynt or join HustlerSocial on Facebook.


'/>"/>
SOURCE Hustler
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Zeus Healthcare Names Larry Havelis as CEO
2. Sanovas CEO Larry Gerrans Featured Speaker at AdvaMed 2011
3. ProUroCare Medical Elects Larry W. Getlin as New Director
4. AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage
5. Larry King to Host 10th Annual American Friends of Rabin Medical Center Broadway on the Hudson Gala
6. National Study: Teen "Heavy" Marijuana Use Up 80 Percent Since 2008, One in Ten Teens Reports Using Marijuana at Least 20 Times a Month
7. Medbox, Inc. Supports Increased Regulation on the California Medical Marijuana Industry
8. Medical Marijuana Frontier, Cannabis Science Brand Extracts Successful Cancer Treatments Confirmed as Squamous Cell Carcinoma and Skin Cancer Patients Report Continued Shrinking of Cancer Cells
9. Medical Marijuana Player, Cannabis Science Issues Earnings Guidance for 2012 Forecasted at $6,846,000 and Potential Increased to $65,740,000 in 2014 with $0.02 Per Share Positive Earnings
10. Medical Marijuana Inc. to Acquire Biotechnology Company PharmaSphere, LLC from Converted Organics
11. WeedMaps Announces Marketing Agreement with the National Organization for the Reform of Marijuana Laws for Website Transformation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 30, 2015  Today we bring you a special edition of #MedicareMonday on Medicare,s ... about some of our Medicare resources and continue highlighting the success of the prescription ... Check out our latest infographics and videos here: http://onphr.ma/1INp9qQ ... ... ...
(Date:7/30/2015)...  Amgen (NASDAQ: AMGN ) today announced ... Key results include: , Total revenues increased ... to $5,370 million, with 6 percent product sales ... Prolia ® (denosumab), Sensipar ® (cinacalcet), ... (denosumab). Unfavorable changes in foreign exchange rates impacted ...
(Date:7/30/2015)... CHENGDU, China , July 30, 2015 ... "Company"), a pharmaceutical company that specializes in the patented ... active pharmaceutical ingredients (API), provided updates regarding the notice ... MKT LLC (the "Exchange") indicating that the Company was ... set forth in Sections 134 and 1101 of the ...
Breaking Medicine Technology:Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2
... poultry ... processing plants., SHREVEPORT, La., Nov. ... poultry processing, was identified,in an October 2007 Watt Poultry USA article ... in large-scale processing plants, University of,Georgia Associate Professor of Poultry Science ...
... American Heart Association Scientific Sessions 2007 ... ... Nov. 6 ARCA Discovery, a privately held,biopharmaceutical company, announced today ... bucindolol, a,next-generation beta-blocker and vasodilator for heart failure, atrial,fibrillation, and arrhythmia, ...
Cached Medicine Technology:FreshFx Recognized for use in the Scalder as a Solution to the 'Yield/Pathogen Reduction Dilemma' 2ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia 2ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia 3ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia 4ARCA Discovery Announces Data Demonstrating Potential for Bucindolol as Targeted Therapy in Heart Failure, Atrial Fibrillation, and Ventricular Arrhythmia 5
(Date:7/31/2015)... ... 31, 2015 , ... Jacksonville-based drug and alcohol rehabilitation center, ... Center. The medical community, social workers, law enforcement, and government officials are all ... the effort to better understand and combat sex trafficking. Lead by sex trafficking ...
(Date:7/31/2015)... ... , ... M3 USA MDLinx.com, source of the Smartest Doc Board Exam Prep ... , The additions of Gastroenterology, Pulmonology and Allergy/Immunology round out an already robust selection ... exam easy and painless. MDLinx offers thousands of board-exam style questions and exam-specific ...
(Date:7/31/2015)... ... July 31, 2015 , ... According to an article published ... if they could reach a consensus on the steps that need to be taken ... group reached 90 percent consensus on a series of steps that each surgeon must ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... educating both readers and potential patients alike on various plastic surgery procedures including, ... covered also include such popular dermatology procedures like Botox and fillers. , ...
(Date:7/31/2015)... ... , ... Transfinder, a software company based in Schenectady, N.Y., achieved record revenue ... for the first six months ended June 30, 2015 compared with the same period ... year’s record-revenue mark of $10.4 million. , “We know what our customers need and ...
Breaking Medicine News(10 mins):Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 2Health News:Lakeview Health Links Sex Trafficking and Addiction in Special Jacksonville Educational Workshop 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 2Health News:Article on Plastic Surgery Consensus Highlights the Duties of Veteran Plastic Surgeons, says Beverly Hills Physicians 3Health News:Cosmetic Town: Now Providing Interactive And Vital Medical Knowledge 2Health News:Transfinder Closes First Half of 2015 with Record Revenue 2
... coverage and access to health care , , FRIDAY, Jan. ... insurance and no regular source of health care are the ... University of Michigan C.S. Mott Children,s Hospital report. , The ... safeguard the health of vulnerable children, said the researchers, who ...
... Global Telemedicine Inc., supplies medical peripherals to the successful installations of ... advancing telemedicine program , ... N. Chelmsford, MA (PRWEB) ... Telemedicine has worked closely with Texas Tech University Health ...
... Jan. 30 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical, Co., Inc. (NYSE ... Chinese medicine ("TCM") based in Chengdu, China,today announced ... of shares,under its previously announced stock repurchase program. ... reducing the number of outstanding shares of its,common ...
... BOSTON, Jan. 30 Neurosilicon,s novel Photoconductive Stimulation Device ... Hung and Colicos titled, Astrocytic Ca2+ Waves Guide CNS ... article appearing in the November 2008 issue of The ... role of neuronal activity in mediating axonal guidance. It ...
... IDEXX Laboratories, Inc. (Nasdaq: IDXX ), ... 2008 were $243.3 million compared to $245.0 million for ... is reported growth adjusted to eliminate the effect of ... businesses acquired, divested or discontinued since October 1, 2007, ...
... ("QLT") (NASDAQ: QLTI ; TSX: QLT) announced the ... "Offer"), which expired at 5:00 p.m. (Eastern time) on January ... 20,000,000 of its common shares (the "Shares") at a price ... million. The purchased Shares represent approximately 26.8% of the Shares ...
Cached Medicine News:Health News:Medical Needs of 6.2 Million U.S. Kids Go Unmet 2Health News:Texas Tech University Health Sciences Center and AMD Global Telemedicine Inc. Expand Telemedicine Program Throughout Texas 2Health News:Texas Tech University Health Sciences Center and AMD Global Telemedicine Inc. Expand Telemedicine Program Throughout Texas 3Health News:Tianyin Pharmaceutical Co., Inc. Begins Initial Share Buyback under its Repurchase Program 2Health News:Tianyin Pharmaceutical Co., Inc. Begins Initial Share Buyback under its Repurchase Program 3Health News:Novel Photoconductive Cellular Depolarization Technology Reveals Insight Into Neuronal Growth, Guidance, and Regeneration 2Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 2Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 3Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 4Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 5Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 6Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 7Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 8Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 9Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 10Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 11Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 12Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 13Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 14Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 15Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 16Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 17Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 18Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 19Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 20Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 21Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 22Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 23Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 24Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 25Health News:IDEXX Laboratories Announces Fourth Quarter and Full Year Results 26Health News:QLT announces final results of tender offer 2
... Biotrace Sterile Barium Sulfate USP is ... and consistent imaging capabilities for todays ... via minimally invasive surgery. Comprised of ... an even diffusion of sterile barium, ...
... Cement consists of a two ... bone cement liquid within a ... polyethylene bag,containing bone cement powder ... interiors of the blister pack,and ...
... Bone Cement consists of a ... containing bone cement liquid within ... sterile polyethylene bag,containing bone cement ... The interiors of the blister ...
... Radiopaque Bone Cement consists of ... sterile,ampule containing bone cement liquid ... a sterile polyethylene bag,containing bone ... pouch. The interiors of the ...
Medicine Products: